European Medicines Agency recommends approval of pomalidomide for the treatment of multiple myeloma

View source ↗

Summary

The EMA recommends approving pomalidomide for the treatment of multiple myeloma, indicating a potential new therapy option for this disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pomalidomide (Pomalidomide)